Marie Chauveau
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home-acquired urinary tract infections.
Journal: The Journal of antimicrobial chemotherapy
Published: May 21, 2024
Comparative effectiveness of empirical antibiotic treatments in methicillin-susceptible Staphylococcus aureus infective endocarditis: A post hoc analysis of a prospective French cohort study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 05, 2023
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: October 12, 2022
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
Journal: The Journal of infection
Published: June 28, 2022
Circulating Regulatory T Cells Expressing Tumor Necrosis Factor Receptor Type 2 Contribute to Sepsis-Induced Immunosuppression in Patients During Septic Shock.
Journal: The Journal of infectious diseases
Published: March 07, 2021
Comparative outcomes of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post hoc analysis of a prospective multicentre French cohort study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: June 02, 2020
Regulatory T Cells Expressing Tumor Necrosis Factor Receptor Type 2 Play a Major Role in CD4+ T-Cell Impairment During Sepsis.
Journal: The Journal of infectious diseases
Published: December 24, 2019
Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study-authors' response.
Journal: The Journal of antimicrobial chemotherapy
Published: August 20, 2019
Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study.
Journal: The Journal of antimicrobial chemotherapy
Published: August 30, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026